本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Trevi Therapeutics Inc.

14.04
+0.71005.33%
盤後14.040.00000.00%16:20 EDT
成交量:143.46萬
成交額:1,979.58萬
市值:18.00億
市盈率:-44.24
高:14.09
開:13.29
低:13.23
收:13.33
52周最高:14.39
52周最低:5.38
股本:1.28億
流通股本:9,708.75萬
量比:1.30
換手率:1.48%
股息:- -
股息率:- -
每股收益(TTM):-0.3173
每股收益(LYR):-0.3173
淨資產收益率:-30.23%
總資產收益率:-20.26%
市淨率:9.82
市盈率(LYR):-44.24

資料載入中...

2024/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/11

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/13

重要事件披露

Form 8-K - Current report
2024/05/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/21

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/25

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/20

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/20

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report